Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Gen-Probe Tepnel
Gen-Probe Tepnel
Activities:
Regulatory
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Analysis
Gen-Probe adds three to leadership team
To support diagnostic products and services firm’s growth
Research & Development
Gen-Probe’s analytical service laboratories pass FDA inspection
Site already certified by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for GMP, GLP and GCP compliance
Research & Development
Gen-Probe expands service offering in Manchester, UK
Increases footprint and hires two managers
Analysis
FDA clears first nucleic acid amplification test to detect Trichomonas Vaginalis
APTIMA assay will improve detection of a potentially serious sexually transmitted infection that is common in women of all ages
Finance
Biotech Outsourcing Strategies cmc
<b>17 June 2010</b><br> Sohuset Conference Centre, Horsholm, Denmark
Research & Development
NCRI Cancer Conference
<b>7 - 10 November 2010</b><br> Liverpool, UK
Finance
BIO-Europe 2010
<b>15 - 17 November 2010</b><br> Munich, Germany
Subscribe now